| Literature DB >> 28111071 |
Constantinos Chronis1, Petko Fiziev1, Bernadett Papp1, Stefan Butz1, Giancarlo Bonora1, Shan Sabri1, Jason Ernst2, Kathrin Plath3.
Abstract
Oct4, Sox2, Klf4, and cMyc (OSKM) reprogram somatic cells to pluripotency. To gain a mechanistic understanding of their function, we mapped OSKM-binding, stage-specific transcription factors (TFs), and chromatin states in discrete reprogramming stages and performed loss- and gain-of-function experiments. We found that OSK predominantly bind active somatic enhancers early in reprogramming and immediately initiate their inactivation genome-wide by inducing the redistribution of somatic TFs away from somatic enhancers to sites elsewhere engaged by OSK, recruiting Hdac1, and repressing the somatic TF Fra1. Pluripotency enhancer selection is a stepwise process that also begins early in reprogramming through collaborative binding of OSK at sites with high OSK-motif density. Most pluripotency enhancers are selected later in the process and require OS and other pluripotency TFs. Somatic and pluripotency TFs modulate reprogramming efficiency when overexpressed by altering OSK targeting, somatic-enhancer inactivation, and pluripotency enhancer selection. Together, our data indicate that collaborative interactions among OSK and with stage-specific TFs direct both somatic-enhancer inactivation and pluripotency-enhancer selection to drive reprogramming.Entities:
Keywords: Klf4; Oct4; Sox2; collaborative binding; enhancers; induced pluripotent stem cells; pluripotency; reprogramming; transcription factors
Mesh:
Substances:
Year: 2017 PMID: 28111071 PMCID: PMC5302508 DOI: 10.1016/j.cell.2016.12.016
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582